Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth
Authors:
- 11 August 2009
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 18 (11) , 1595-1604
Abstract
(2009). Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opinion on Investigational Drugs: Vol. 18, No. 11, pp. 1595-1604.Keywords
This publication has 25 references indexed in Scilit:
- Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian CancerCancer Research, 2007
- Selection of patients with hepatocellular carcinoma for liver transplantationBritish Journal of Surgery, 2005
- Promoting apoptosis as a strategy for cancer drug discoveryNature Reviews Cancer, 2005
- Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinomaCancer, 2005
- Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristicsJournal of Cancer Research and Clinical Oncology, 2004
- Protein Transduction Strategies for Target and Mechanism Validation2004
- Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathwayOncogene, 2003
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002
- ApoptosisCell, 2002
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996